However, OSR2 expression, decreased only by kaempferol treatment, is commonly downregulated in endometrial cancer suggesting that some transcripts associated with risk have varied expression patterns as a result of kaempferol treatment [56]. The gene discussed is OSR2; the disease is endometrial cancer.